Belvedere Trading LLC Reata Pharmaceuticals Inc Transaction History

Belvedere Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$79.22 - $105.37 $44,204 - $58,796	-558 Reduced 11.74%	4,193 $427,000
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $60,466 - $182,613	-1,960 Reduced 29.21%	4,751 $431,000
Q4 2022 Feb 14, 2023	SELL	$22.15 - $42.11 $39,692 - $75,461	-1,792 Reduced 21.07%	6,711 $254,000
Q3 2022 Oct 26, 2022	SELL	$19.41 - $36.49 $94,022 - $176,757	-4,844 Reduced 36.29%	8,503 $279,000
Q2 2022 Jul 21, 2022	BUY	$20.71 - $36.5 $225,304 - $397,083	10,879 Added 440.8%	13,347 $470,000
Q1 2022 Apr 20, 2022	BUY	$24.12 - $39.6 $59,528 - $97,732	2,468 New	2,468 $78,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.